189 related articles for article (PubMed ID: 1412150)
1. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
[TBL] [Abstract][Full Text] [Related]
2. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
Vatier J; Célice-Pingaud C; Farinotti R
Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
[TBL] [Abstract][Full Text] [Related]
3. An artificial stomach-duodenum model for the in-vitro evaluation of antacids.
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Aliment Pharmacol Ther; 1992 Aug; 6(4):447-58. PubMed ID: 1420737
[TBL] [Abstract][Full Text] [Related]
4. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
[TBL] [Abstract][Full Text] [Related]
5. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
Vatier J; Lionnet F; Vitre MT
Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
[TBL] [Abstract][Full Text] [Related]
6. New approach for the in vitro evaluation of antacids.
Vatier J; Vallot T; Vitre MT; Mignon M
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):175-9. PubMed ID: 2185759
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
[TBL] [Abstract][Full Text] [Related]
8. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
Vatier J; Ramdani A; Vitré MT; Mignon M
Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
[TBL] [Abstract][Full Text] [Related]
9. A model of an 'artificial stomach' for assessing the characteristics of an antacid.
Vatier J; Lionnet F; Vitré MT; Mignon M
Aliment Pharmacol Ther; 1988 Oct; 2(5):461-70. PubMed ID: 2979268
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
Lin MS; Sun P; Yu HY
J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the antacid properties of Gelox in a dynamic milieu using the artificial stomach apparatus].
Vatier J; Vitre MT; Lionnet F; Mignon M
Therapie; 1989; 44(1):43-8. PubMed ID: 2734720
[TBL] [Abstract][Full Text] [Related]
12. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
Vatier J; Vitre MT; Vallot T; Mignon M
Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
[TBL] [Abstract][Full Text] [Related]
13. Fate of oral neutralizing antacid and its effect on postprandial gastric secretion and emptying.
Deering TB; Carlson GL; Malagelada JR; Duenes JA; McCall JT
Gastroenterology; 1979 Nov; 77(5):986-90. PubMed ID: 39873
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
Tytgat GN; Simoneau G
Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in gastric acidity and antacid distribution: is a single pH electrode sufficient?
Fisher RS; Sher DJ; Donahue D; Knight LC; Maurer A; Urbain JL; Krevsky B
Am J Gastroenterol; 1997 Feb; 92(2):263-70. PubMed ID: 9040203
[TBL] [Abstract][Full Text] [Related]
16. Interactions of cimetidine and ranitidine with aluminum-containing antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model.
Vatier J; Harman A; Castela N; Droy-Lefaix MT; Farinotti R
J Pharm Sci; 1994 Jul; 83(7):962-6. PubMed ID: 7965675
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the interaction between antacid and gastric mucosa using an "artificial stomach" model including gastric mucosa.
Vatier JL; Gao Z; Fu-Cheng XM; Vitre MT; Levy DA; Cohen G; Mignon M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1206-11. PubMed ID: 1469628
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single dose of antacid on gastric and duodenal bulb pH in duodenal ulcer patients.
Bendsten F; Rune SJ
Scand J Gastroenterol; 1988 Oct; 23(8):935-40. PubMed ID: 3201130
[TBL] [Abstract][Full Text] [Related]
19. Interaction of liquid aluminium phosphate and aluminium hydroxide with the gastric acid profile. Influence of food components and timing of meals.
Schürer-Maly CC; Varga L; Halter F
Scand J Gastroenterol; 1992 Apr; 27(4):263-9. PubMed ID: 1589702
[TBL] [Abstract][Full Text] [Related]
20. [Antacid activity of citrate-bicarbonate complex of effervescent formulations of ranitidine. In vitro analysis using 'artificial stomach-duodenum' model].
Vatier J; Cai S; Slama A; Farinotti R
Therapie; 1996; 51(2):139-46. PubMed ID: 8763048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
